0 Shares 817 Views

Biomarkers and Alzheimer’s Disease: Dr. Neil Buckholtz

Dr. Neil Buckholtz, Director of the Division of Neuroscience at the National Institute on Aging/NIH, describes how biomarkers—in blood, cerebrospinal fluid and brain imaging—are advancing our ability to detect the earliest stages of Alzheimer’s, track its progression, and determine the effectiveness of promising treatments.


The information on Alzheimers.help is intended for informational purposes only and should not be taken as medical advice.  Please contact your medical professional about specific questions you may have about Alzheimer’s and Dementia diseases.

Most from this category